Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05564026 · ClinicalTrials.gov registry record
Molecular Epidemiology of Pediatric Germ Cell Tumors
A clinical trial of Germ Cell Tumor and Yolk Sac Tumor, sponsored by Children's Oncology Group.
- Recruiting
- Registry status
- 1,151
- Enrollment target
- 1
- Study location
NCT05564026 is a study of Germ Cell Tumor and Yolk Sac Tumor that is actively recruiting participants, run by Children's Oncology Group. The registered enrollment target is 1,151 participants, above the 287-participant average among 19 other Germ Cell Tumor trials with a reported enrollment target (301% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05564026, a study of Germ Cell Tumor and Yolk Sac Tumor, is actively recruiting participants, sponsored by Children's Oncology Group.
- RECRUITING
- Registry status
- 1,151 participants
- Enrollment target
- 1
- Study location
Study Summary
A Non-Therapeutic Study that aims to establish a cohort of GCT survivors to understand short term and long-term adverse effects of treatment and to conduct molecular analyses to improve risk stratification.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Blood Sample Collection
- OTHER Tumor Specimen Collection
- OTHER Germline DNA Samples
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,151 participants |
| Start Date | 2023-04-12 |
| Est. Completion | 2027-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05564026
The ClinicalTrials.gov registry entry for NCT05564026 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,151 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 287-participant average among 19 other Germ Cell Tumor trials with a reported enrollment target (301% higher). The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Germ Cell Tumor appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT05564026 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05564026 about?
NCT05564026 is a clinical study titled "Molecular Epidemiology of Pediatric Germ Cell Tumors". A Non-Therapeutic Study that aims to establish a cohort of GCT survivors to understand short term and long-term adverse effects of treatment and to conduct molecular analyses to improve risk stratification.
What is the current status of trial NCT05564026?
This trial is currently recruiting. The enrollment target is 1,151 participants. The study started on 2023-04-12. Estimated completion is 2027-06-30.
What conditions does trial NCT05564026 study?
This clinical trial studies the following conditions: Germ Cell Tumor, Yolk Sac Tumor, Choriocarcinoma, Mixed Germ Cell Tumor, Teratoma.
What interventions are being tested in trial NCT05564026?
The interventions under investigation include: Questionnaire Administration (OTHER), Blood Sample Collection (PROCEDURE), Tumor Specimen Collection (OTHER), Germline DNA Samples (OTHER).
Who is sponsoring clinical trial NCT05564026?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05564026 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Germ Cell Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
RECRUITING · Phase 1
-
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
RECRUITING · Phase 3
-
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
RECRUITING · Phase 3
-
Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
RECRUITING · Phase 2
-
Germ Cell Tumor and Testicular Tumor DNA Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.